|
Patients with early Parkinson's disease show better symptom control
|
16 April 2008 |
|
Novartis to first acquire 25% stake from Nestlé for USD 143.18 per share for USD 11 billion
|
08 April 2008 |
|
Rasilez® reduces left ventricular hypertrophy, a powerful predictor of heart disease
|
01 April 2008 |
|
Femara® helps protect against return of breast cancer
|
12 March 2008 |
|
Novartis Vaccines Institute for Global Health (NVGH) is the first institute with nonprofit mission
|
25 February 2008 |
|
Novartis achieves record results in 2007 underscoring benefits of strategic healthcare portfolio
|
21 January 2008 |
|
Galvus®, a new oral treatment for type 2 diabetes, receives positive opinion
|
20 December 2007 |
|
Novartis further strengthens biologics capabilities in expansion of MorphoSys collaboration
|
05 December 2007 |
|
Novartis withdraws its application to extend the marketing authorisation for Zometa
|
21 November 2007 |
|
Menveo(TM) (MenACWY-CRM) vaccine to demonstrate an excellent immune response in infants
|
19 November 2007 |